Surgery Partners, Inc. (SGRY) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for Surgery Partners, Inc. (SGRY): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 52/100 — a percentile rank of Surgery Partners, Inc.’s fundamentals against Services peers, weakest on financial health. A quality ranking, not a price prediction.
| Market cap | $1.7B |
| P / S | 0.5× |
| EV / EBITDA | 8.2× |
| Gross margin | 100.0% |
| Operating margin | 11.7% |
| Net margin | 2.4% |
| Return on equity | -5.3% |
| ROIC | 4.8% |
| Revenue growth | 4.0% |
| Debt / equity | 2.2× |
| Dividend yield | 0.0% |
Is Surgery Partners, Inc. overvalued? P/S looks undervalued vs its 5-year range; EV/EBITDA looks undervalued vs its 5-year range; P/B looks fair vs its 5-year range.
Independent of the events above — derived from Surgery Partners, Inc.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact